Episode 24: Costs of adverse events in Renal Cell Carcinoma

Update: 2023-10-23

Description

Learn from the experts about the costs associated with irAEs in patients treated for Renal Cell Carcinoma. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologists Dr. Daniel Geynisman and Dr. Bradley McGregor, MD for an informative and high yield discussion regarding real and hidden costs of adverse events and how this impacts patients.

Comments

In Channel

Episode 25: Adrenal Insufficiency- What patients need to know.

2024-07-0746:31

Episode 23: Emotional impact of side effects on patients and caregivers

2023-05-1730:39

Episode 21: Thyroid disease in cancer patients. What you need to know as a patient!

2022-11-2714:46

Episode 20: Patient experience, advocacy and immune toxicities

2022-09-2633:11

Episode 24: Costs of adverse events in Renal Cell Carcinoma

2023-10-2325:19

Episode 22: Germline Variants, Toxicities and ICI

2023-04-1318:59

Episode 19: ICI use in Special Populations

2022-02-0840:34

Episode 18: Immune mediated neurological toxicities (Part 2)

2021-12-1939:10

Episode 17: Autoimmune Type 1 Diabetes: Challenge for our patients and clinicians

2021-11-1733:54

Episode 16: Learning about Immune mediated Adverse events from a trainees persepective

2021-09-2114:58

Episode 15: Neuro-toxicities from Immune checkpoint Blockade: Rare and complex (Part 1)

2021-07-1315:23

Episode 14: Immune Mediated Liver Injury

2021-06-1727:16

Episode 13: Skin Toxicities from Immune Checkpoint Inhibitors (PART 2): Common and perplexing

2021-05-2617:09

Episode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexing

2021-05-0317:59

Episode 10: Immune Mediated Pulmonary Toxicities

2021-03-3027:13

Episode 9: Immune Mediated Cardiac Toxicities: Diagnostic challenges, management and novel discoveries.

2021-03-1627:03

Episode 8: Immune Mediated Colitis- Novel discoveries and novel therapies

2021-03-0327:10

Episode 7: Immune Mediated Colitis and lessons learnt from multidisciplinary team based management.

2021-02-1632:48

Episode 6: Rheumatic adverse events: Discussions on biomarkers, collaborations and more.

2021-02-0124:29

Episode 5: Immune mediated Myositis and Myalgia's: Diagnosis & management for the non-Rheumatologist

2021-01-1816:33

00:00

Episode 24: Costs of adverse events in Renal Cell Carcinoma

#box-pro-ellipsis-17598766195621{-webkit-line-clamp:2;}Episode 24: Costs of adverse events in Renal Cell Carcinoma

Episode 24: Costs of adverse events in Renal Cell Carcinoma

Afreen Shariff

Episode 24: Costs of adverse events in Renal Cell Carcinoma